首页> Pathology, research and practice> Prevalence of protein C receptor (PROCR) is associated with inferior clinical outcome in Breast invasive ductal carcinoma.

Prevalence of protein C receptor (PROCR) is associated with inferior clinical outcome in Breast invasive ductal carcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Qiu,Yan

第一单位： Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

作者： Qiu,Yan ^[1] ; Zhong,Xiaorong ^[2] ; Zhang,Zhang ^[3] ; Wei,Bing ^[3] ; Ye,Feng ^[4] ; Bu,Hong ^[5]

作者单位： Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. ^[1] Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; Laboratory of Molecular Diagnosis of Cancer, State Key Laboratory of Biotherapy, National Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. ^[2] Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. ^[3] Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, PR China. ^[4] Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China; Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, PR China; Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. Electronic address: molecularpathology@hotmail.com. ^[5]

关键词 Breast invasive ductal carcinoma Metastases Neoplasm stem cell PROCR Prognosis